Stunted telomeres found in heart disease
Patients with cardiomyopathy have abnormally short telomeres in the cells responsible for heart contraction, Stanford researchers find. This disease hallmark opens new pathways for drug discovery.
Pathologist Robert Rouse dies
Rouse was known for his precision in surgical pathology, his meticulous use of language, his calm demeanor and his subtle sense of humor.
A model for stemming opioid crisis
Increasing the availability of naloxone, cutting opioid prescriptions by 25 percent and expanding drug-treatment programs could reduce opioid-related deaths by 6,000 over 10 years, Stanford researchers estimate.
Test predicts lymphoma therapy success
Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.
Anesthesiologist Kevin Malott dies
Malott, who was honored as the favorite instructor of Stanford’s anesthesiology residents in 2014, enjoyed providing care for young children.
Cell death via trigger waves
In a cell, death is akin to falling dominoes: One death-inducing molecule activates another, and so on, until the entire cell is shut down, a new Stanford study finds.
Common skin cancer linked to other cancers
Frequent skin cancers due to mutations in genes responsible for repairing DNA are linked to a threefold risk of unrelated cancers, according to a Stanford study. The finding could help identify people for more vigilant screening.
Brain circuit tied to sociability
Autism spectrum disorder is marked by severe social deficits. Stanford researchers were able to reverse those types of deficits in mice by activating a single brain circuit.
Device helps kids with autism read looks
Wearing a device that identifies other people’s facial expressions can help children with autism develop better social skills, a Stanford pilot study has demonstrated.
Depression, blood levels of substance linked
Investigators at Stanford and elsewhere have shown, for the first time in humans, that low blood levels of acetyl-L-carnitine track with the severity and duration of depression.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.